![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FUCA2 |
Gene summary for FUCA2 |
![]() |
Gene information | Species | Human | Gene symbol | FUCA2 | Gene ID | 2519 |
Gene name | alpha-L-fucosidase 2 | |
Gene Alias | dJ20N2.5 | |
Cytomap | 6q24.2 | |
Gene Type | protein-coding | GO ID | GO:0005975 | UniProtAcc | Q9BTY2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2519 | FUCA2 | LZE4T | Human | Esophagus | ESCC | 6.79e-12 | 3.30e-01 | 0.0811 |
2519 | FUCA2 | LZE7T | Human | Esophagus | ESCC | 1.22e-07 | 6.31e-01 | 0.0667 |
2519 | FUCA2 | LZE8T | Human | Esophagus | ESCC | 4.18e-06 | 2.93e-01 | 0.067 |
2519 | FUCA2 | LZE20T | Human | Esophagus | ESCC | 9.92e-06 | 1.36e-01 | 0.0662 |
2519 | FUCA2 | LZE22T | Human | Esophagus | ESCC | 8.80e-05 | 5.14e-01 | 0.068 |
2519 | FUCA2 | LZE24T | Human | Esophagus | ESCC | 1.84e-09 | 4.30e-01 | 0.0596 |
2519 | FUCA2 | LZE21T | Human | Esophagus | ESCC | 1.90e-06 | 2.06e-01 | 0.0655 |
2519 | FUCA2 | LZE6T | Human | Esophagus | ESCC | 1.33e-03 | 3.44e-01 | 0.0845 |
2519 | FUCA2 | P1T-E | Human | Esophagus | ESCC | 3.89e-03 | 4.47e-01 | 0.0875 |
2519 | FUCA2 | P2T-E | Human | Esophagus | ESCC | 7.55e-07 | 1.01e-01 | 0.1177 |
2519 | FUCA2 | P4T-E | Human | Esophagus | ESCC | 7.62e-24 | 6.07e-01 | 0.1323 |
2519 | FUCA2 | P5T-E | Human | Esophagus | ESCC | 6.08e-19 | 4.59e-01 | 0.1327 |
2519 | FUCA2 | P8T-E | Human | Esophagus | ESCC | 3.04e-48 | 9.60e-01 | 0.0889 |
2519 | FUCA2 | P9T-E | Human | Esophagus | ESCC | 8.57e-18 | 5.48e-01 | 0.1131 |
2519 | FUCA2 | P10T-E | Human | Esophagus | ESCC | 1.85e-43 | 7.56e-01 | 0.116 |
2519 | FUCA2 | P11T-E | Human | Esophagus | ESCC | 2.55e-15 | 6.84e-01 | 0.1426 |
2519 | FUCA2 | P15T-E | Human | Esophagus | ESCC | 3.18e-16 | 4.72e-01 | 0.1149 |
2519 | FUCA2 | P16T-E | Human | Esophagus | ESCC | 8.63e-13 | 2.27e-01 | 0.1153 |
2519 | FUCA2 | P17T-E | Human | Esophagus | ESCC | 2.79e-07 | 5.04e-01 | 0.1278 |
2519 | FUCA2 | P19T-E | Human | Esophagus | ESCC | 3.45e-11 | 1.11e+00 | 0.1662 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0044403111 | Esophagus | ESCC | biological process involved in symbiotic interaction | 186/8552 | 290/18723 | 1.43e-10 | 4.16e-09 | 186 |
GO:0051701111 | Esophagus | ESCC | biological process involved in interaction with host | 135/8552 | 203/18723 | 1.49e-09 | 3.49e-08 | 135 |
GO:0052126111 | Esophagus | ESCC | movement in host environment | 117/8552 | 175/18723 | 1.14e-08 | 2.26e-07 | 117 |
GO:00059969 | Esophagus | ESCC | monosaccharide metabolic process | 159/8552 | 257/18723 | 1.11e-07 | 1.81e-06 | 159 |
GO:00193189 | Esophagus | ESCC | hexose metabolic process | 147/8552 | 237/18723 | 2.63e-07 | 3.94e-06 | 147 |
GO:0044409111 | Esophagus | ESCC | entry into host | 96/8552 | 151/18723 | 6.73e-06 | 6.84e-05 | 96 |
GO:0043903111 | Esophagus | ESCC | regulation of biological process involved in symbiotic interaction | 49/8552 | 72/18723 | 1.03e-04 | 7.26e-04 | 49 |
GO:19016574 | Esophagus | ESCC | glycosyl compound metabolic process | 57/8552 | 88/18723 | 2.32e-04 | 1.44e-03 | 57 |
GO:19011362 | Esophagus | ESCC | carbohydrate derivative catabolic process | 99/8552 | 172/18723 | 1.11e-03 | 5.54e-03 | 99 |
GO:005237219 | Esophagus | ESCC | modulation by symbiont of entry into host | 32/8552 | 49/18723 | 4.39e-03 | 1.73e-02 | 32 |
GO:00161373 | Esophagus | ESCC | glycoside metabolic process | 16/8552 | 22/18723 | 9.46e-03 | 3.28e-02 | 16 |
GO:004440312 | Liver | Cirrhotic | biological process involved in symbiotic interaction | 131/4634 | 290/18723 | 2.00e-14 | 1.84e-12 | 131 |
GO:005170112 | Liver | Cirrhotic | biological process involved in interaction with host | 88/4634 | 203/18723 | 4.55e-09 | 1.82e-07 | 88 |
GO:000599612 | Liver | Cirrhotic | monosaccharide metabolic process | 104/4634 | 257/18723 | 1.74e-08 | 6.32e-07 | 104 |
GO:001931812 | Liver | Cirrhotic | hexose metabolic process | 97/4634 | 237/18723 | 2.67e-08 | 9.16e-07 | 97 |
GO:00521267 | Liver | Cirrhotic | movement in host environment | 75/4634 | 175/18723 | 1.08e-07 | 3.07e-06 | 75 |
GO:00439037 | Liver | Cirrhotic | regulation of biological process involved in symbiotic interaction | 34/4634 | 72/18723 | 2.86e-05 | 3.64e-04 | 34 |
GO:00444097 | Liver | Cirrhotic | entry into host | 58/4634 | 151/18723 | 1.33e-04 | 1.30e-03 | 58 |
GO:19016572 | Liver | Cirrhotic | glycosyl compound metabolic process | 37/4634 | 88/18723 | 2.70e-04 | 2.40e-03 | 37 |
GO:0016137 | Liver | Cirrhotic | glycoside metabolic process | 11/4634 | 22/18723 | 9.18e-03 | 4.21e-02 | 11 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0414222 | Esophagus | ESCC | Lysosome | 102/4205 | 132/8465 | 5.11e-11 | 7.13e-10 | 3.65e-10 | 102 |
hsa0414232 | Esophagus | ESCC | Lysosome | 102/4205 | 132/8465 | 5.11e-11 | 7.13e-10 | 3.65e-10 | 102 |
hsa041424 | Liver | Cirrhotic | Lysosome | 68/2530 | 132/8465 | 1.34e-07 | 1.97e-06 | 1.21e-06 | 68 |
hsa0414211 | Liver | Cirrhotic | Lysosome | 68/2530 | 132/8465 | 1.34e-07 | 1.97e-06 | 1.21e-06 | 68 |
hsa041422 | Liver | HCC | Lysosome | 100/4020 | 132/8465 | 2.32e-11 | 4.31e-10 | 2.40e-10 | 100 |
hsa00511 | Liver | HCC | Other glycan degradation | 15/4020 | 18/8465 | 1.96e-03 | 6.91e-03 | 3.84e-03 | 15 |
hsa041423 | Liver | HCC | Lysosome | 100/4020 | 132/8465 | 2.32e-11 | 4.31e-10 | 2.40e-10 | 100 |
hsa005111 | Liver | HCC | Other glycan degradation | 15/4020 | 18/8465 | 1.96e-03 | 6.91e-03 | 3.84e-03 | 15 |
hsa041425 | Oral cavity | OSCC | Lysosome | 87/3704 | 132/8465 | 1.97e-07 | 1.35e-06 | 6.86e-07 | 87 |
hsa0414212 | Oral cavity | OSCC | Lysosome | 87/3704 | 132/8465 | 1.97e-07 | 1.35e-06 | 6.86e-07 | 87 |
hsa0414221 | Oral cavity | LP | Lysosome | 67/2418 | 132/8465 | 5.13e-08 | 7.77e-07 | 5.01e-07 | 67 |
hsa0414231 | Oral cavity | LP | Lysosome | 67/2418 | 132/8465 | 5.13e-08 | 7.77e-07 | 5.01e-07 | 67 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FUCA2 | SNV | Missense_Mutation | novel | c.538N>C | p.Tyr180His | p.Y180H | Q9BTY2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-33-4587-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Chemotherapy | etoposide | PD |
FUCA2 | SNV | Missense_Mutation | c.559N>C | p.Phe187Leu | p.F187L | Q9BTY2 | protein_coding | deleterious(0.02) | possibly_damaging(0.819) | TCGA-BR-4368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
FUCA2 | SNV | Missense_Mutation | novel | c.613N>A | p.Pro205Thr | p.P205T | Q9BTY2 | protein_coding | tolerated(0.05) | benign(0.062) | TCGA-VQ-A8E0-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Fluorouracil | PD |
FUCA2 | SNV | Missense_Mutation | novel | c.1297N>C | p.Trp433Arg | p.W433R | Q9BTY2 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-VQ-A91K-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |